Responsive image

Under Auspices

International Osteoporosis Foundation


DAY II- 28.09.2019 (Saturday)

S07 08.00-9.40 Osteoporosis - not only postmenopausal
Chairman: Misiorowski W., Korkosz M.
Franek E. Diagnostic algorithm of osteoporosis in endocrine diseases
Misiorowski W. Osteoporosis in the aging male
Więcek A. Management in chronic kidney disease - mineral and bone disorder (CKD-MBD)
Kalinka E. Osteoporosis in the course of pharmacotherapy of breast and prostate cancer
Osieleniec J. Osteoporosis in systemic connective tissue diseases
Nawrat-Szołtysik A. Opara J., Miodońska Z., Adamczuk E., Matyja B., Polak A. Quality of life of elderly men with osteoporosis
09.40-10.10 Coffee break
S8 10.10-11.45 Advances in the treatment of osteoarthritis
Chairman: Reginster J-Y., Jaworek J.
Reginster J-Y. Advances in the treatment of osteoarthritis
Białoszewski D. Preparations given in intra-articular injections in the treatment of osteoarthritis - do they actually cure?
Woroń J. Treatment of pain in osteoarthritis
Badurski J. Musculoskeletal manifestations of hyperparathyroidism
Jaworek J. Role of physiotherapy in prophylactic and therapy of osteoarthrosis
S9 11.45-13.00 Aging and sarcopenia
Chairman: Grodzicki T., Povoroznyuk V.
Grodzicki T. Healthy aging
Berwecka M., Warzecha M. The most recent definition of sarcopenia
Povoroznyuk V. Sarcopenia - prevention and treatment
Warzecha M., Berwecka M., Amarowicz J., Czerwinski E. Falls risk assessment, strength, gait speed, muscle mass
13.00-14.00 LUNCH
S10 14.00-15.30 The increase of the untreated – possible interventions
Chairman: Brzosko M., Głuszko P.
Brzosko M. Current status of osteoporosis treatment in Poland
Glinkowski W., Narloch J., Krasuski K., Śliwczyński A. Mortality after proximal femur fracture in Poland
Czerwiński E., Borowy P., Amarowicz J. Why does the number of the non-treated osteoporosis patients increase in Poland?
Amarowicz J., Czerwiński E. Kumorek A. Importance of FLS in fracture prevention
Głuszko P. Polish program for the coordination of osteoporotic fracture prevention POWER
S11 15.30-17.15 Miscellaneous
Chairman: Lorenc R., Konstantynowicz J.
Palicka V. Role of genetics in fracture risk prediction
Konstantynowicz J., Abramowicz P., Stawicki K. Osteogenesis imperfecta in adults: a brief overview and current challenges
Lorenc R. Position of Bone Turnover Markers (BTM) in Diagnostic and Treatment of Osteoporosis
Borowy P. Bone metabolism disorders in rare diseases
Kucharz E. Osseous involvement in patients with sarcoidosis
Berwecka M. Czerwinski E,. Amarowicz J., Warzecha M., Kumorek A. FRAX and TBS in fracture risk assessment
17.15 Closing ceremony



Polish Osteoarthrology Society

European Foundation of Osteoporosis and Musculoskeletal Diseases

Polish Osteoporosis Foundation

Department of Bone and Joint Diseases UJ CM